Skip to content

Self Management and Remote Monitoring of Heart Failure and Chronic Obstructive Airways Disease using a Smart Phone Application

Self Management and Remote Monitoring of Heart Failure and Chronic Obstructive Airways Disease using a Smart Phone Application in patients referred of admitted to hospital with these conditions. Assessing impact on quality of life, symptoms, and hospitalisations.

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621001459819
Enrollment
55
Registered
2021-10-26
Start date
2021-11-01
Completion date
2022-04-20
Last updated
2022-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Use of a Smart phone application to encourage self-management with remote monitoring in patients admitted or referred to an East Metropolitan Heath Service hospital in Western Australia [Armadale Health Service (AHS), Royal Perth Hospital (RPH) or SJOG Midland Public and Private Hospital (SJOGMPPH)] with heart failure of chronic obstructive pulmonary disease: 1. The primary aim is to determine impact on quality of life. 2. Secondary aims include a. impact on symptom assessment scores b. change in average hospital length of stay in the 1 month, 3 months and 6 months following the intervention c. patient satisfaction with using the application Hypothesis The use of a Smart phone application to improve self-management with remote monitoring will significantly improve the domains of physical and emotional health, and positively impact symptom assessment and reduce average length of stay.

Interventions

Patients randomised to the intervention group enter their symptoms daily for 30 days on the smart phone application. The application used is called Mentegram. The symptoms that are questioned are different for heart failure and COPD. The estimated time each day to enter the symptoms is 2 minutes. A deterioration in symptom control results in an immediate automatic prompt to contact their General Practitioner. Patients who do not report having contacted their GP within 24 hours then contacted

Patients randomised to the intervention group enter their symptoms daily for 30 days on the smart phone application. The application used is called Mentegram. The symptoms that are questioned are different for heart failure and COPD. The estimated time each day to enter the symptoms is 2 minutes. A deterioration in symptom control results in an immediate automatic prompt to contact their General Practitioner. Patients who do not report having contacted their GP within 24 hours then contacted via the research team using telephone to determine whether the patient has seen/is planning to see their GP, if they have not made contact with their GP and why. The hospital research team will look at the patient details and form an individualised response which includes, but is not limited to, alerting the patient’s nominated GP and their hospital treating team Additionally patients who do not enter their daily report are contacted via telephone to perform a welfare check. Weekly links to self-management education tutorials will be sent to the participants through the application. This education material consists of links to publicly available education material from the Lung Foundation Australia (lungfoundation.com.au), the Heart Foundation (www.heartfoundation.org.au) and WA Department of Health (www.healthywa.wa.gov.au). The estimated time to read the educational material is 10 minutes, and use of the link is tracked via the Smart phone application. The subjects can enter the data at any location and adherence is tracked through the smart phone application.

Sponsors

Armadale Health Service
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients referred or admitted to hospital with a diagnosis of COPD or chronic heart failure.

Exclusion criteria

1. No regular access to a smart phone or email 2. Cognitive impairment precluding use of technology or unable to provide informed consent 3. Previously participated in this trial or the pilot trial 4. Children (<18years old)

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026